PDB Short entry for 1YDT HEADER COMPLEX (PHOSPHOTRANSFERASE/INHIBITOR) 24-JUL-96 1YDT TITLE STRUCTURE OF CAMP-DEPENDENT PROTEIN KINASE, ALPHA-CATALYTIC TITLE 2 SUBUNIT IN COMPLEX WITH H89 PROTEIN KINASE INHIBITOR N-[2- TITLE 3 (4-BROMOCINNAMYLAMINO)ETHYL]-5-ISOQUINOLINE COMPND MOL_ID: 1; COMPND 2 MOLECULE: C-AMP-DEPENDENT PROTEIN KINASE; COMPND 3 CHAIN: E; COMPND 4 FRAGMENT: CATALYTIC SUBUNIT; COMPND 5 SYNONYM: CAPK, PKA C-ALPHA; COMPND 6 EC: 2.7.1.37; COMPND 7 ENGINEERED: YES; COMPND 8 OTHER_DETAILS: ALPHA ISOENZYME; COMPND 9 MOL_ID: 2; COMPND 10 MOLECULE: PROTEIN KINASE INHIBITOR PEPTIDE; COMPND 11 CHAIN: I; COMPND 12 SYNONYM: PKI, PKI-ALPHA; COMPND 13 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: BOS TAURUS; SOURCE 3 ORGANISM_COMMON: CATTLE; SOURCE 4 ORGANISM_TAXID: 9913; SOURCE 5 ORGAN: HEART; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 MOL_ID: 2 KEYWDS COMPLEX (PHOSPHOTRANSFERASE/INHIBITOR), TRANSFERASE, CAMP, KEYWDS 2 PHOSPHORYLATION, ISOQUINOLINE SULFONAMIDE, SERINE/THREONINE- KEYWDS 3 PROTEIN KINASE, ATP-BINDING EXPDTA X-RAY DIFFRACTION AUTHOR R.A.ENGH,A.GIROD,V.KINZEL,R.HUBER,D.BOSSEMEYER REVDAT 2 24-FEB-09 1YDT 1 VERSN REVDAT 1 01-APR-97 1YDT 0 JRNL AUTH R.A.ENGH,A.GIROD,V.KINZEL,R.HUBER,D.BOSSEMEYER JRNL TITL CRYSTAL STRUCTURES OF CATALYTIC SUBUNIT OF JRNL TITL 2 CAMP-DEPENDENT PROTEIN KINASE IN COMPLEX WITH JRNL TITL 3 ISOQUINOLINESULFONYL PROTEIN KINASE INHIBITORS H7, JRNL TITL 4 H8, AND H89. STRUCTURAL IMPLICATIONS FOR JRNL TITL 5 SELECTIVITY. JRNL REF J.BIOL.CHEM. V. 271 26157 1996 JRNL REFN ISSN 0021-9258 JRNL PMID 8824261 JRNL DOI 10.1074/JBC.271.42.26157 REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH D.BOSSEMEYER,R.A.ENGH,V.KINZEL,H.PONSTINGL,R.HUBER REMARK 1 TITL PHOSPHOTRANSFERASE AND SUBSTRATE BINDING MECHANISM REMARK 1 TITL 2 OF THE CAMP-DEPENDENT PROTEIN KINASE CATALYTIC REMARK 1 TITL 3 SUBUNIT FROM PORCINE HEART AS DEDUCED FROM THE 2.0 REMARK 1 TITL 4 A STRUCTURE OF THE COMPLEX WITH MN2+ ADENYLYL REMARK 1 TITL 5 IMIDODIPHOSPHATE AND INHIBITOR PEPTIDE PKI(5-24) REMARK 1 REF EMBO J. V. 12 849 1993 REMARK 1 REFN ISSN 0261-4189 REMARK 1 REFERENCE 2 REMARK 1 AUTH S.WIEMANN,V.KINZEL,W.PYERIN REMARK 1 TITL CLONING OF THE C ALPHA CATALYTIC SUBUNIT OF THE REMARK 1 TITL 2 BOVINE CAMP-DEPENDENT PROTEIN KINASE REMARK 1 REF BIOCHIM.BIOPHYS.ACTA V.1171 93 1992 REMARK 1 REFN ISSN 0006-3002 REMARK 1 REFERENCE 3 REMARK 1 AUTH T.CHIJIWA,A.MISHIMA,M.HAGIWARA,M.SANO,K.HAYASHI, REMARK 1 AUTH 2 T.INOUE,K.NAITO,T.TOSHIOKA,H.HIDAKA REMARK 1 TITL INHIBITION OF FORSKOLIN-INDUCED NEURITE OUTGROWTH REMARK 1 TITL 2 AND PROTEIN PHOSPHORYLATION BY A NEWLY SYNTHESIZED REMARK 1 TITL 3 SELECTIVE INHIBITOR OF CYCLIC AMP-DEPENDENT REMARK 1 TITL 4 PROTEIN KINASE, N-[2-(PARA-BROMOCINNAMYLAMINO) REMARK 1 TITL 5 ETHYL]-5-ISOQUINOLINESULFONAMIDE (H-89), OF PC12D REMARK 1 TITL 6 PHEOCHROMOCYTOMA CELLS REMARK 1 REF J.BIOL.CHEM. V. 265 5267 1990 REMARK 1 REFN ISSN 0021-9258 REMARK 1 REFERENCE 4 REMARK 1 AUTH H.HIDAKA,M.INAGAKI,S.KAWAMOTO,Y.SASAKI REMARK 1 TITL ISOQUINOLINESULFONAMIDES, NOVEL AND POTENT REMARK 1 TITL 2 INHIBITORS OF CYCLIC NUCLEOTIDE DEPENDENT PROTEIN REMARK 1 TITL 3 KINASE AND PROTEIN KINASE C REMARK 1 REF BIOCHEMISTRY V. 23 5036 1984 REMARK 1 REFN ISSN 0006-2960 REMARK 2 REMARK 2 RESOLUTION. 2.30 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : X-PLOR REMARK 3 AUTHORS : BRUNGER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.30 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 6.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 3.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 NUMBER OF REFLECTIONS : NULL REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : NULL REMARK 3 FREE R VALUE TEST SET SELECTION : NULL REMARK 3 R VALUE (WORKING SET) : 0.194 REMARK 3 FREE R VALUE : NULL REMARK 3 FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (A) : NULL REMARK 3 BIN RESOLUTION RANGE LOW (A) : NULL REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 REFLECTIONS IN BIN (WORKING SET) : NULL REMARK 3 BIN R VALUE (WORKING SET) : NULL REMARK 3 BIN FREE R VALUE : NULL REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 BIN FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2927 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 35 REMARK 3 SOLVENT ATOMS : 21 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM SIGMAA (A) : NULL REMARK 3 LOW RESOLUTION CUTOFF (A) : NULL REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM C-V SIGMAA (A) : NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : NULL REMARK 3 BOND ANGLES (DEGREES) : NULL REMARK 3 DIHEDRAL ANGLES (DEGREES) : NULL REMARK 3 IMPROPER ANGLES (DEGREES) : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : NULL REMARK 3 TOPOLOGY FILE 1 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: ONLY THE WATER MOLECULES IN THE REMARK 3 VICINITY OF THE BOUND H-89 INHIBITOR MOLECULE HAVE BEEN REMARK 3 MODELED. REMARK 4 REMARK 4 1YDT COMPLIES WITH FORMAT V. 3.15, 01-DEC-08 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY BNL. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : NULL REMARK 200 TEMPERATURE (KELVIN) : NULL REMARK 200 PH : 6.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : NULL REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.5418 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : AREA DETECTOR REMARK 200 DETECTOR MANUFACTURER : SIEMENS-NICOLET X100 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : SAINT REMARK 200 DATA SCALING SOFTWARE : SAINT REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 12157 REMARK 200 RESOLUTION RANGE HIGH (A) : NULL REMARK 200 RESOLUTION RANGE LOW (A) : NULL REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 62.0 REMARK 200 DATA REDUNDANCY : NULL REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : NULL REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : NULL REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : NULL REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: NULL REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: NULL REMARK 200 SOFTWARE USED: X-PLOR REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 53.31 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.63 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 15 % METHANOL, 70 MILLIMOLAR SODIUM REMARK 280 SULFATE, 20 MILLIMOLAR MES-BIS-TRIS PH 6.5, 279K USING HANGING REMARK 280 DROP DIFFUSION., VAPOR DIFFUSION - HANGING DROP REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 36.79000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 40.29000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 38.14000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 40.29000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 36.79000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 38.14000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: E, I REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY E 1 REMARK 465 ASN E 2 REMARK 465 ALA E 3 REMARK 465 ALA E 4 REMARK 465 ALA E 5 REMARK 465 ALA E 6 REMARK 465 LYS E 7 REMARK 465 LYS E 8 REMARK 465 GLY E 9 REMARK 465 SER E 10 REMARK 465 GLU E 11 REMARK 465 GLN E 12 REMARK 465 GLU E 13 REMARK 465 SER E 14 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND LENGTHS REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,2(A3,1X,A1,I4,A1,1X,A4,3X),1X,F6.3) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 RES CSSEQI ATM2 DEVIATION REMARK 500 CYS E 199 CB CYS E 199 SG -0.134 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASN E 36 65.20 26.86 REMARK 500 ASP E 41 17.69 -68.07 REMARK 500 ASN E 99 107.45 -165.70 REMARK 500 ASP E 166 41.57 -150.57 REMARK 500 ASP E 184 87.81 55.77 REMARK 500 ASN E 216 -153.68 -132.94 REMARK 500 LEU E 273 57.70 -100.07 REMARK 500 ASP E 276 94.54 -68.61 REMARK 500 ALA E 298 -19.49 -48.29 REMARK 500 LYS E 319 69.45 -107.21 REMARK 500 ARG I 15 58.70 -111.79 REMARK 500 HIS I 23 -119.78 -95.10 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE IQB E 351 DBREF 1YDT E 1 350 UNP P00517 KAPCA_BOVIN 1 350 DBREF 1YDT I 5 24 UNP P04541 IPKA_HUMANX 5 24 SEQADV 1YDT ALA E 124 UNP P00517 PRO 124 CONFLICT SEQADV 1YDT TPO E 197 UNP P00517 THR 197 MODIFIED RESIDUE SEQADV 1YDT ASP E 286 UNP P00517 ASN 286 CONFLICT SEQADV 1YDT SEP E 338 UNP P00517 SER 338 MODIFIED RESIDUE SEQRES 1 E 350 GLY ASN ALA ALA ALA ALA LYS LYS GLY SER GLU GLN GLU SEQRES 2 E 350 SER VAL LYS GLU PHE LEU ALA LYS ALA LYS GLU ASP PHE SEQRES 3 E 350 LEU LYS LYS TRP GLU ASN PRO ALA GLN ASN THR ALA HIS SEQRES 4 E 350 LEU ASP GLN PHE GLU ARG ILE LYS THR LEU GLY THR GLY SEQRES 5 E 350 SER PHE GLY ARG VAL MET LEU VAL LYS HIS MET GLU THR SEQRES 6 E 350 GLY ASN HIS TYR ALA MET LYS ILE LEU ASP LYS GLN LYS SEQRES 7 E 350 VAL VAL LYS LEU LYS GLN ILE GLU HIS THR LEU ASN GLU SEQRES 8 E 350 LYS ARG ILE LEU GLN ALA VAL ASN PHE PRO PHE LEU VAL SEQRES 9 E 350 LYS LEU GLU PHE SER PHE LYS ASP ASN SER ASN LEU TYR SEQRES 10 E 350 MET VAL MET GLU TYR VAL ALA GLY GLY GLU MET PHE SER SEQRES 11 E 350 HIS LEU ARG ARG ILE GLY ARG PHE SER GLU PRO HIS ALA SEQRES 12 E 350 ARG PHE TYR ALA ALA GLN ILE VAL LEU THR PHE GLU TYR SEQRES 13 E 350 LEU HIS SER LEU ASP LEU ILE TYR ARG ASP LEU LYS PRO SEQRES 14 E 350 GLU ASN LEU LEU ILE ASP GLN GLN GLY TYR ILE GLN VAL SEQRES 15 E 350 THR ASP PHE GLY PHE ALA LYS ARG VAL LYS GLY ARG THR SEQRES 16 E 350 TRP TPO LEU CYS GLY THR PRO GLU TYR LEU ALA PRO GLU SEQRES 17 E 350 ILE ILE LEU SER LYS GLY TYR ASN LYS ALA VAL ASP TRP SEQRES 18 E 350 TRP ALA LEU GLY VAL LEU ILE TYR GLU MET ALA ALA GLY SEQRES 19 E 350 TYR PRO PRO PHE PHE ALA ASP GLN PRO ILE GLN ILE TYR SEQRES 20 E 350 GLU LYS ILE VAL SER GLY LYS VAL ARG PHE PRO SER HIS SEQRES 21 E 350 PHE SER SER ASP LEU LYS ASP LEU LEU ARG ASN LEU LEU SEQRES 22 E 350 GLN VAL ASP LEU THR LYS ARG PHE GLY ASN LEU LYS ASP SEQRES 23 E 350 GLY VAL ASN ASP ILE LYS ASN HIS LYS TRP PHE ALA THR SEQRES 24 E 350 THR ASP TRP ILE ALA ILE TYR GLN ARG LYS VAL GLU ALA SEQRES 25 E 350 PRO PHE ILE PRO LYS PHE LYS GLY PRO GLY ASP THR SER SEQRES 26 E 350 ASN PHE ASP ASP TYR GLU GLU GLU GLU ILE ARG VAL SEP SEQRES 27 E 350 ILE ASN GLU LYS CYS GLY LYS GLU PHE SER GLU PHE SEQRES 1 I 20 THR THR TYR ALA ASP PHE ILE ALA SER GLY ARG THR GLY SEQRES 2 I 20 ARG ARG ASN ALA ILE HIS ASP MODRES 1YDT TPO E 197 THR PHOSPHOTHREONINE MODRES 1YDT SEP E 338 SER PHOSPHOSERINE HET TPO E 197 11 HET SEP E 338 10 HET IQB E 351 27 HETNAM TPO PHOSPHOTHREONINE HETNAM SEP PHOSPHOSERINE HETNAM IQB N-[2-(4-BROMOCINNAMYLAMINO)ETHYL]-5-ISOQUINOLINE HETNAM 2 IQB SULFONAMIDE HETSYN TPO PHOSPHONOTHREONINE HETSYN SEP PHOSPHONOSERINE HETSYN IQB H-89 FORMUL 1 TPO C4 H10 N O6 P FORMUL 1 SEP C3 H8 N O6 P FORMUL 3 IQB C20 H20 BR N3 O2 S FORMUL 4 HOH *21(H2 O) HELIX 1 1 LYS E 16 GLU E 31 1 16 HELIX 2 2 LEU E 40 GLN E 42 5 3 HELIX 3 3 LYS E 76 LYS E 81 1 6 HELIX 4 4 ILE E 85 ALA E 97 1 13 HELIX 5 5 MET E 128 ILE E 135 1 8 HELIX 6 6 GLU E 140 LEU E 160 1 21 HELIX 7 7 PRO E 169 ASN E 171 5 3 HELIX 8 8 PRO E 202 TYR E 204 5 3 HELIX 9 9 PRO E 207 ILE E 210 1 4 HELIX 10 10 LYS E 217 ALA E 233 5 17 HELIX 11 11 PRO E 243 SER E 252 1 10 HELIX 12 12 SER E 263 LEU E 272 1 10 HELIX 13 13 GLY E 287 LYS E 292 5 6 HELIX 14 14 LYS E 295 THR E 299 5 5 HELIX 15 15 TRP E 302 TYR E 306 1 5 HELIX 16 16 GLY E 344 PHE E 347 1 4 HELIX 17 17 THR I 6 ILE I 11 1 6 SHEET 1 A 5 GLY E 50 GLY E 52 0 SHEET 2 A 5 GLY E 55 HIS E 62 -1 N VAL E 57 O GLY E 50 SHEET 3 A 5 ASN E 67 ASP E 75 -1 N ILE E 73 O ARG E 56 SHEET 4 A 5 ASN E 115 GLU E 121 -1 N MET E 120 O ALA E 70 SHEET 5 A 5 LEU E 106 LYS E 111 -1 N PHE E 110 O TYR E 117 SHEET 1 B 2 LEU E 172 ILE E 174 0 SHEET 2 B 2 ILE E 180 VAL E 182 -1 N GLN E 181 O LEU E 173 SHEET 1 C 2 PHE E 43 THR E 48 0 SHEET 2 C 2 MET E 58 HIS E 62 -1 N LYS E 61 O GLU E 44 LINK N TPO E 197 C TRP E 196 1555 1555 1.33 LINK C TPO E 197 N LEU E 198 1555 1555 1.33 LINK N SEP E 338 C VAL E 337 1555 1555 1.32 LINK C SEP E 338 N ILE E 339 1555 1555 1.33 SITE 1 AC1 14 LEU E 49 THR E 51 GLY E 55 VAL E 57 SITE 2 AC1 14 ALA E 70 GLU E 121 VAL E 123 GLU E 170 SITE 3 AC1 14 ASN E 171 LEU E 173 THR E 183 PHE E 327 SITE 4 AC1 14 HOH E 413 HOH E 424 CRYST1 73.580 76.280 80.580 90.00 90.00 90.00 P 21 21 21 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.013591 0.000000 0.000000 0.00000 SCALE2 0.000000 0.013110 0.000000 0.00000 SCALE3 0.000000 0.000000 0.012410 0.00000